← Back
$RAPP All transactions

Rapport Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$81K

Shares

2,839

Price

$29

Filed

Mar 31

Insider

Name

Gault Cheryl

Title

Chief Operating Officer

CIK

0001839046

Roles

Officer

Transaction Details

Transaction Date

2026-03-30

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

159,914

Footnotes

These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2025. | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.42 to $28.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.42 to $28.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

Filing Info

Accession No.

0001193125-26-134684

Form Type

4

Issuer CIK

0002012593

Gault Cheryl's History

Date Ticker Type Value
2026-03-30 RAPP $201K
2026-03-30 RAPP $81K
2025-11-26 RAPP M $9K
2025-11-26 RAPP $150K
2025-11-26 RAPP M $0
2025-09-08 RAPP M $9K
2025-09-08 RAPP $192K
2025-09-08 RAPP M $0

Other Insiders at RAPP (90d)

Insider Bought Sold Last
Third Rock Ventures V, L.P. $17.2M 2026-04-17
Gault Cheryl
Chief Operating Officer
$201K 2026-03-30
Yeleswaram Krishnaswamy
Chief Development Officer
$1.8M 2026-04-17